Longevity & Anti-Ageing Peptides

Longevity peptides target the fundamental biological mechanisms of ageing — telomere attrition, mitochondrial dysfunction, immune senescence, and epigenetic drift — rather than treating downstream disease. This emerging field draws from geroscience research and seeks to extend healthspan (years of healthy function) alongside lifespan, addressing what researchers call the 'hallmarks of ageing' at the molecular level.

Epitalon (Epithalon) is the most researched longevity peptide. A synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation, Epitalon stimulates telomerase activity — the enzyme responsible for maintaining telomere length. Shortened telomeres are strongly associated with biological ageing and age-related disease risk. Epitalon has demonstrated telomere elongation in human cell cultures and has been studied in human clinical trials in Russia over several decades, with data suggesting reduced mortality and improved health markers in elderly subjects.

MOTS-c is a mitochondrial-derived peptide encoded in mitochondrial DNA — making it one of a class of compounds called mitochondrial-derived peptides (MDPs). It acts as a metabolic regulator, activating AMPK pathways, improving insulin sensitivity, and supporting mitochondrial function. As mitochondrial health declines with age — a phenomenon called mitochondrial dysfunction, one of the primary hallmarks of ageing — MOTS-c may help restore metabolic efficiency. Preclinical studies show significant effects on muscle function, exercise performance, and lifespan in animal models.

GHK-Cu bridges the longevity and healing categories. At the gene expression level, GHK-Cu has been shown to restore gene activity patterns in aged tissue toward a younger profile — upregulating repair and regeneration genes while downregulating inflammatory and pro-ageing gene networks. This broad epigenetic reset makes it a genuinely multi-modal longevity intervention.

In the UK, longevity peptides are unregulated research chemicals. The British Longevity Society and academic centres at Oxford, Cambridge, and UCL are increasingly active in ageing biology research, but clinical translation remains early-stage. MHRA regulation would apply if these compounds were marketed as medicines. Online longevity sources frequently propose combining Epitalon with MOTS-c, GHK-Cu, and NAD+ precursors (NMN/NR), but the human evidence base for any of these as a longevity intervention is limited and combinations have not been clinically validated — see our evidence-grading methodology.